Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 548

1.

Prophylaxis and treatment of deep vein thrombosis in general surgery.

Gutt CN, Oniu T, Wolkener F, Mehrabi A, Mistry S, Büchler MW.

Am J Surg. 2005 Jan;189(1):14-22. Review.

PMID:
15701484
2.
3.

Management of venous thromboembolism: a systematic review for a practice guideline.

Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB.

Ann Intern Med. 2007 Feb 6;146(3):211-22. Epub 2007 Jan 29. Review. Erratum in: Ann Intern Med. 2007 Mar 6;146(5):396. Hoffman, Lawrence V [corrected to Hofmann, Lawrence V].

PMID:
17261856
4.

Diagnosis and management of venous thrombosis in the surgical patient.

Jackson MR.

Semin Thromb Hemost. 1998;24 Suppl 1:67-76. Review.

PMID:
9840695
6.

Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.

Själander A, Jansson JH, Bergqvist D, Eriksson H, Carlberg B, Svensson P.

J Intern Med. 2008 Jan;263(1):52-60. Review.

7.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
8.

Clinical experience with ximelagatran in orthopaedic surgery.

Eriksson B.

Drugs. 2004;64 Suppl 1:27-35. Review.

PMID:
15586625
9.

Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.

Nishioka J, Goodin S.

J Oncol Pharm Pract. 2007 Jun;13(2):85-97. Review.

PMID:
17873108
11.

Prevention of venous thromboembolism in high-risk surgical and medical patients.

Prandoni P, Sabbion P, Tanduo C, Errigo G, Zanon E, Bernardi E.

Semin Vasc Med. 2001;1(1):61-70. Review.

PMID:
15199515
12.

Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism.

Anderson DR, O'Brien BJ.

Pharmacoeconomics. 1997 Jul;12(1):17-29. Review.

PMID:
10169385
13.
14.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
15.

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.

PMID:
17906973
16.

Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D, Hamulyák K, Francis CW, Marder VJ, Raskob GE.

Arch Intern Med. 2001 Sep 10;161(16):1952-60. Review.

PMID:
11525697
17.

Short- and long-term results after thrombolytic treatment of deep venous thrombosis.

Schweizer J, Kirch W, Koch R, Elix H, Hellner G, Forkmann L, Graf A.

J Am Coll Cardiol. 2000 Oct;36(4):1336-43.

18.

Advanced management of acute iliofemoral deep venous thrombosis: emergency department and beyond.

Pollack CV Jr.

Ann Emerg Med. 2011 Jun;57(6):590-9. doi: 10.1016/j.annemergmed.2010.11.031. Epub 2011 Feb 8. Review.

PMID:
21306786
19.

Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.

[No authors listed]

Prescrire Int. 2005 Aug;14(78):127-32.

PMID:
16106594
20.

Supplemental Content

Support Center